Kinase Inhibitors Market to Grow at a CAGR of 4% from 2019 to 2027, Reaching US$ 64.9 Billion | Exclusive Report by Transparency Market Research

𝐊𝐢𝐧𝐚𝐬𝐞 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 is estimated to reach a value of ~US$ 64.9 Bn by the end of 2027, it is projected to expand at a CAGR of ~4% from 2019 to 2027.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=818&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐢𝐧𝐚𝐬𝐞 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐃𝐫𝐢𝐯𝐞𝐫𝐬

Increase in incidence of cancer patients among population is the major cause of growth of the global kinase inhibitors market. According to the Cancer Research UK data, around 17 million new cases of cancer were reported worldwide in 2018 and around 27.5 million new cases of cancer are likely to be reported worldwide each year by 2040.

Expanding indications of existing and pipeline kinase inhibitors also boost the market growth. BCR-ABL TKIs, which were earlier approved for treating CML, are now indicated for treating acute lymphoblastic leukemia (ALL) and gastrointestinal tumors. Similarly, EGFR TKIs are approved for an array of indications such as pancreatic cancer, breast cancer, and non-small cell lung cancer.

𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Novartis AG,,Pfizer,,Johnson & Johnson,,AstraZeneca,,Bristol-Myers Squibb,,Boehringer Ingelheim International GmbH,,Bayer AG, F.,Hoffmann-La Roche Ltd, ,Eisai Co., Ltd

𝐊𝐢𝐧𝐚𝐬𝐞 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐓𝐲𝐩𝐞

Non-receptor Tyrosine Kinase Inhibitors
Bruton's Tyrosine Kinase (BTK) Inhibitors
BCR-ABL
Janus Kinase (JAK) Inhibitor
Mesenchymal Epithelial Transition Growth Factor (c-MET)
Spleen Tyrosine Kinase (SYK) Inhibitors
Others

Receptor Tyrosine Kinase Inhibitors

VEGFR
PDGFR
EGFR
ALK
HER2
Others

Multikinase inhibitors

Serine/Threonine Kinase Inhibitors
Protein Kinase C Inhibitors
RHO Kinase Inhibitors
Others

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Oncology
Lung Cancer
Renal Cell Cancer
Breast Cancer
Others
Inflammatory Diseases
Others

𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥

Hospital Pharmacies
Independent Pharmacies
Online Pharmacies

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=818<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰: 𝐊𝐢𝐧𝐚𝐬𝐞 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

In terms of region, the global kinase inhibitors market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.

The current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027

The study also offers a list of recommendations, highlights, and useful insights of the market which is likely to help new companies willing to enter the market and existing companies to increase market shares and help in the decision-making process

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Emerging trends in the kinase inhibitors market include personalized medicine approaches, combination therapies, and the integration of artificial intelligence and machine learning in drug discovery processes. Moreover, there is a growing focus on developing kinase inhibitors with improved efficacy and safety profiles.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future outlook for the kinase inhibitors market is promising, with continued innovation driving therapeutic advancements. As precision medicine gains traction, the demand for targeted therapies like kinase inhibitors is expected to soar, offering new hope for patients with various diseases.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Key areas of focus for market study include understanding the mechanisms of kinase inhibition, exploring new therapeutic targets, evaluating the efficacy and safety of kinase inhibitors, and assessing market dynamics and trends.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐄𝐥𝐞𝐜𝐭𝐫𝐢𝐜 𝐀𝐫𝐜 𝐅𝐮𝐫𝐧𝐚𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/17/2671515/0/en/Electric-Arc-Furnaces-Market-to-Grow-at-a-CAGR-of-5-7-from-2023-to-2031-Reaching-US-1-3-Million-Exclusive-Report-by-Transparency-Market-Research.html

𝐑𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐓𝐡𝐞𝐫𝐦𝐚𝐥 𝐎𝐱𝐢𝐝𝐢𝐳𝐞𝐫 (𝐑𝐓𝐎) 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/17/2671448/0/en/Regenerative-Thermal-Oxidizer-RTO-Market-Likely-to-Reach-US-12-6-Billion-Expected-to-Rise-at-a-CAGR-of-4-9-From-2023-to-2031-Transparency-Market-Research-Inc.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.